Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06424938Not ApplicableCompleted

Postoperative Analgesia in Major Gynecological Cancer Surgeries

Role: lead

NCT06426394Completed

Effect of Positive End-expiratory Pressure on Gastic Residual Volume

Role: lead

NCT07077889Completed

Postoperative Chronic Pain in Gynaecological Cancer Surgery

Role: lead

NCT07077863Completed

Transversus Abdominis Plane Block for Postoperative Pain Management in Gynaecological Cancer Surgery

Role: lead

NCT06648330Completed

Blood Lactate Level With Paraaortic Lymph Node Dissection

Role: lead

All 5 trials loaded